Interleukin-10 and prostaglandin E2 have complementary but distinct suppressive effects on Toll-like receptor-mediated dendritic cell activation in ovarian carcinoma

Antibody-mediated depletion of immunosuppressive factors from ovarian carcinoma-associated ascites for investigation of paracrine versus autocrine effects

(2017) E. Brencicova et al.   JOURNAL OF IMMUNOLOGICAL METHODS

PGE2 differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP2/EP4)

(2013) Neil J. Poloso et al.   MOLECULAR IMMUNOLOGY

Host Indoleamine 2,3-Dioxygenase: Contribution to Systemic Acquired Tumor Tolerance

(2012) Theodore S. Johnson et al.   IMMUNOLOGICAL INVESTIGATIONS

PGE2-Driven Induction and Maintenance of Cancer-Associated Myeloid-Derived Suppressor Cells

(2012) Nataša Obermajer et al.   IMMUNOLOGICAL INVESTIGATIONS

A Dynamic Inflammatory Cytokine Network in the Human Ovarian Cancer Microenvironment

(2011) H. Kulbe et al.   CANCER RESEARCH

Sensitization of ovarian carcinoma cells with zoledronate restores the cytotoxic capacity of Vγ9Vδ2 T cells impaired by the prostaglandin E2 immunosuppressive factor: Implications for immunotherapy

(2011) Vincent Lavoué et al.   INTERNATIONAL JOURNAL OF CANCER

Increased IL-10 mRNA expression in tumor-associated macrophage correlated with late stage of lung cancer

(2011) Rui Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

M2 Macrophages Induced by Prostaglandin E2 and IL-6 from Cervical Carcinoma Are Switched to Activated M1 Macrophages by CD4+ Th1 Cells

(2011) M. Heusinkveld et al.   JOURNAL OF IMMUNOLOGY

HMGB1 and RAGE in Inflammation and Cancer

(2010) Gary P. Sims et al.   Annual Review of Immunology

Cyclooxygenase-2 and Cancer Treatment: Understanding the Risk Should Be Worth the Reward

(2010) D. G. Menter et al.   CLINICAL CANCER RESEARCH

Ovarian cancer creates a suppressive microenvironment to escape immune elimination

(2010) Refika Yigit et al.   GYNECOLOGIC ONCOLOGY

Ovarian cancer immunotherapy: opportunities, progresses and challenges

(2010) Bei Liu et al.   Journal of Hematology & Oncology

A Role for IL-1 Receptor-Associated Kinase-M in Prostaglandin E2-Induced Immunosuppression Post-Bone Marrow Transplantation

(2010) L. L. N. Hubbard et al.   JOURNAL OF IMMUNOLOGY

In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells

(2009) U. K. Scarlett et al.   CANCER RESEARCH

Tumour-derived prostaglandin E2and transforming growth factor-β synergize to inhibit plasmacytoid dendritic cell-derived interferon-α

(2009) Isabelle Bekeredjian-Ding et al.   IMMUNOLOGY

Evaluation of immune inhibitory cytokine profiles in epithelial ovarian carcinoma

(2009) Li-li Chen et al.   JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH

Monitoring of IL-10 in the serum of patients with advanced ovarian cancer: Results from a prospective pilot-study

(2008) Alexander Mustea et al.   CYTOKINE

Dendritic cell subsets in the peritoneal fluid and peripheral blood of women suffering from ovarian cancer

(2008) I. Wertel et al.   CYTOMETRY PART B-CLINICAL CYTOMETRY

Inflammatory signals in dendritic cell activation and the induction of adaptive immunity

(2008) Olivier Joffre et al.   IMMUNOLOGICAL REVIEWS